Wolde Deneke, Eguale Tadesse, Alemayehu Haile, Medhin Girmay, Haile Aklilu Feleke, Pirs Mateja, Strašek Smrdel Katja, Avberšek Jana, Kušar Darja, Cerar Kišek Tjaša, Janko Tea, Steyer Andrej, Starčič Erjavec Marjanca
Department of Medical Laboratory Science, College of Medicine and Health Sciences, Wachemo University, Hossana P.O. Box 667, Ethiopia.
Aklilu Lemma Institute of Pathobiology, Addis Ababa University, Addis Ababa P.O. Box 1176, Ethiopia.
Antibiotics (Basel). 2024 Jan 18;13(1):93. doi: 10.3390/antibiotics13010093.
Antimicrobial resistance of is a growing problem in both developed and developing countries. This study aimed to investigate the phenotypic antimicrobial resistance of isolates ( = 260) isolated from the stool specimen of patients attending public health facilities in Addis Ababa and Hossana. This study also aimed to characterize phenotypically confirmed extended-spectrum beta-lactamase (ESBL)-producing isolates ( = 22) using whole-genome sequencing. Resistance to 18 different antimicrobials was assessed using the disc diffusion method according to the European Committee on Antimicrobial Susceptibility Testing (EUCAST) guidelines. The highest resistance rate among the isolates was found for ampicillin (52.7%), followed by trimethoprim-sulfamethoxazole (29.6%). Of all isolates, 50 (19.2%) were multidrug-resistant and 22 (8.5%) were ESBL producers. ESBL genes were detected in 94.7% of the sequenced isolates, and multiple β-lactamase genes were detected in 57.9% of the isolates. The predominant ESBL gene identified was (78.9%). The gene was detected in combination with other ESBL genes in 57.9% of the isolates, while only one of the sequenced isolates contained the gene alone. The gene was detected in three isolates. The genes and as well as and were confirmed to coexist in 52.6% and 10.5% of the sequenced isolates, respectively. In addition, was identified together with and in one isolate, and in one isolate, together with and was found. The results obtained show that measures need to be taken to reduce the spread of drug resistance and ensure the long-term use of available antimicrobials.
在发达国家和发展中国家,抗菌药物耐药性都是一个日益严重的问题。本研究旨在调查从亚的斯亚贝巴和霍桑纳公共卫生机构就诊患者的粪便标本中分离出的[具体细菌名称]菌株(n = 260)的表型抗菌药物耐药性。本研究还旨在使用全基因组测序对表型确认的产超广谱β-内酰胺酶(ESBL)的[具体细菌名称]菌株(n = 22)进行特征分析。根据欧洲抗菌药物敏感性试验委员会(EUCAST)指南,采用纸片扩散法评估对18种不同抗菌药物的耐药性。[具体细菌名称]菌株中耐药率最高的是氨苄西林(52.7%),其次是甲氧苄啶-磺胺甲恶唑(29.6%)。在所有分离株中,50株(19.2%)为多重耐药,22株(8.5%)为ESBL生产者。在94.7%的测序[具体细菌名称]分离株中检测到ESBL基因,在57.9%的分离株中检测到多个β-内酰胺酶基因。鉴定出的主要ESBL基因是[具体基因名称](78.9%)。在57.9%的分离株中检测到[具体基因名称]基因与其他ESBL基因组合,而在测序的分离株中只有一株单独含有[具体基因名称]基因。在三株分离株中检测到[具体基因名称]基因。[具体基因名称]基因以及[其他基因名称]基因分别在52.6%和10.5%的测序[具体细菌名称]分离株中被证实共存。此外,在一株分离株中鉴定出[具体基因名称]与[其他基因名称]和[其他基因名称]在一起,在一株分离株中发现[具体基因名称]与[其他基因名称]和[其他基因名称]在一起。获得的结果表明,需要采取措施减少耐药性的传播,并确保现有抗菌药物的长期使用。